These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23416198)

  • 1. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.
    Yu X; Vasiljevic S; Mitchell DA; Crispin M; Scanlan CN
    J Mol Biol; 2013 Apr; 425(8):1253-8. PubMed ID: 23416198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a receptor required for the anti-inflammatory activity of IVIG.
    Anthony RM; Wermeling F; Karlsson MC; Ravetch JV
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19571-8. PubMed ID: 19036920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
    Holla A; Skerra A
    Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.
    Galustian C; Park CG; Chai W; Kiso M; Bruening SA; Kang YS; Steinman RM; Feizi T
    Int Immunol; 2004 Jun; 16(6):853-66. PubMed ID: 15136555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
    Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of DC-SIGN for mannose- and fucose-containing glycans.
    van Liempt E; Bank CM; Mehta P; Garciá-Vallejo JJ; Kawar ZS; Geyer R; Alvarez RA; Cummings RD; Kooyk Yv; van Die I
    FEBS Lett; 2006 Nov; 580(26):6123-31. PubMed ID: 17055489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris.
    Cukan MC; Hopkins D; Burnina I; Button M; Giaccone E; Houston-Cummings NR; Jiang Y; Li F; Mallem M; Mitchell T; Moore R; Nylen A; Prinz B; Rios S; Sharkey N; Zha D; Hamilton S; Li H; Stadheim TA
    J Immunol Methods; 2012 Dec; 386(1-2):34-42. PubMed ID: 22982058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
    Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human DC-SIGN and CD23 do not interact with human IgG.
    Temming AR; Dekkers G; van de Bovenkamp FS; Plomp HR; Bentlage AEH; Szittner Z; Derksen NIL; Wuhrer M; Rispens T; Vidarsson G
    Sci Rep; 2019 Jul; 9(1):9995. PubMed ID: 31292524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycosylation of antibodies and their pathogenic effect].
    Hernández-Pando R; Olivares N
    Rev Invest Clin; 2013; 65(6):515-23. PubMed ID: 24687359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal affinity chromatography analysis of constructs of DC-SIGN, DC-SIGNR and LSECtin extend evidence for affinity to agalactosylated N-glycans.
    Yabe R; Tateno H; Hirabayashi J
    FEBS J; 2010 Oct; 277(19):4010-26. PubMed ID: 20840590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.
    Anthony RM; Kobayashi T; Wermeling F; Ravetch JV
    Nature; 2011 Jun; 475(7354):110-3. PubMed ID: 21685887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semen clusterin is a novel DC-SIGN ligand.
    Sabatte J; Faigle W; Ceballos A; Morelle W; Rodríguez Rodrígues C; Remes Lenicov F; Thépaut M; Fieschi F; Malchiodi E; Fernández M; Arenzana-Seisdedos F; Lortat-Jacob H; Michalski JC; Geffner J; Amigorena S
    J Immunol; 2011 Nov; 187(10):5299-309. PubMed ID: 22013110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
    Soilleux EJ
    Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
    van Gisbergen KP; Aarnoudse CA; Meijer GA; Geijtenbeek TB; van Kooyk Y
    Cancer Res; 2005 Jul; 65(13):5935-44. PubMed ID: 15994972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.
    Anthony RM; Ravetch JV
    J Clin Immunol; 2010 May; 30 Suppl 1():S9-14. PubMed ID: 20480216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells.
    Nonaka M; Ma BY; Murai R; Nakamura N; Baba M; Kawasaki N; Hodohara K; Asano S; Kawasaki T
    J Immunol; 2008 Mar; 180(5):3347-56. PubMed ID: 18292560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A close look at human IgG sialylation and subclass distribution after lectin fractionation.
    Stadlmann J; Weber A; Pabst M; Anderle H; Kunert R; Ehrlich HJ; Peter Schwarz H; Altmann F
    Proteomics; 2009 Sep; 9(17):4143-53. PubMed ID: 19688751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.
    Requena M; Bouhlal H; Nasreddine N; Saidi H; Gody JC; Aubry S; Grésenguet G; Kazatchkine MD; Sekaly RP; Bélec L; Hocini H
    Immunology; 2008 Apr; 123(4):508-18. PubMed ID: 17999675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
    Anumula KR
    J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.